Dividends Calendar Earnings Calendar
APVO

APVO | Aptevo Therapeutics

Aptevo Therapeutics
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Seattle, Washington, United States

Trade prices

  • Volume:
  • Market Cap: 128.01M
  • Prev closed: 1.62
  • Open: 1.62
  • High: 1.72
  • Low: 1.62
  • 52 week low: 1.11
  • 52 week high: 6.35
  • Dividends:No Dividends

Next ER: May 12, 2021  After Market Closes



Top Stories (APVO)

    Company Profile

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients? lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology ? the ADAPTIR? modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 12, 2021
    May 11, 2021-1.74 / -1.42.42M / 2.16MBeat!
    March 31, 2021-1.81 / -1.512.37M / 1.74MBeat!
    November 11, 2020-2.15 / -2.051.5M / 1.48MBeat!
    August 17, 2020- / -2.12- / 105K
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 12, 2021 21.9100 22.0800
    22.7589
    21.3500
    29.26K 0.27%
    May 11, 2021 21.8500 22.4600
    23.3100
    21.6085
    55.12K -1.13%
    May 10, 2021 22.1000 23.7000
    24.9200
    21.6001
    72.19K -6.36%
    May 7, 2021 23.6000 23.7100
    25.1600
    23.6000
    16.64K -0.46%
    May 6, 2021 23.7100 25.1531
    25.1531
    23.5100
    17.99K -4.93%
    May 5, 2021 24.9400 26.2000
    27.3800
    24.9400
    50.59K -3.26%
    May 4, 2021 25.7800 26.0000
    26.9100
    25.2600
    18.41K -2.42%
    May 3, 2021 26.4200 26.5100
    27.5950
    25.4601
    51.61K -1.09%
    Apr 30, 2021 26.7100 26.4900
    29.0400
    26.4500
    29.18K -2.3%
    Apr 29, 2021 27.3400 29.0000
    29.0000
    26.8500
    52.66K -4.97%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2016
    • Employees:80

    News

    News for (APVO)

    This company doesn't provide a dividend.


    Talk about Aptevo Therapeutics below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 12, 2021 (Same day)

    tm wen meg wix lite fosl jack amwl onem paas sono tsem 


    Jump to (Finance sites)

    Their Official Profiles 

    LinkedIn

    Other stocks 

    baba rht jnj ash dish lrcx kr len schw lyb mrvl gwre 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.